Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature | JCO Precision Oncology
Survival curves of breast cancer patients stratified by TIL count in... | Download Scientific Diagram
Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics | npj Breast Cancer
Breast cancer survival by molecular subtype: a population-based analysis of cancer registry data. - Abstract - Europe PMC
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
Breast cancer prognosis by molecular subtype. Survival curves... | Download Scientific Diagram
Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and Survival | Anticancer Research
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
The influence of stage at diagnosis and molecular subtype on breast cancer patient survival: a hospital-based multi-center study | Cancer Communications | Full Text
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry - ScienceDirect
Long-term survival and stage I breast cancer subtypes - ScienceDirect
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
Frontiers | Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer | npj Breast Cancer
Relationship Between Molecular Subtypes and Overall Survival of Breast Cancer in Bandung – Biomedical and Pharmacology Journal
Ki‑67 index value and progesterone receptor status can predict prognosis and suitable treatment in node‑negative breast cancer patients with estrogen receptor‑positive and HER2‑negative tumors
Breast Cancer Subtypes And Prognosis | BCTT
Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China | BMC Cancer | Full Text
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer - Yuhan Yue, Junqing Liang, Yuruo
Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study - Maaren - 2019 - International Journal of Cancer - Wiley Online Library
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Long-term survival and stage I breast cancer subtypes - ScienceDirect
Les 12 questions les plus souvent posées sur le cancer du #sein en consultation - HC Ceuta, Centro Médico de Especialidades | Centro Médico de Especialidades
Nomogram Model of LNR Predicts Survival in Premenopausal Patients with Node-positive Luminal Breast Cancer | Anticancer Research
